BioLineRx (BLRX) Tops Q1 EPS by 13c

BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.02), $0.13 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
• SpaceX receives Baa1 rating from Moody's with stable outlook